Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma

Introduction: The presence of HER-2 has been shown to be a prognostic factor in many kinds of cancers, but its role in head and neck squamous cell carcinoma (HNSCC) is not still defined. The purpose of the current study is to investigate the role of HER-2 in HNSCC and its correlation with various cl...

Full description

Bibliographic Details
Main Authors: Bijan Khademi, Behzad Khademi, Abbas Ghaderi, Seyd Fakhroddin Hosseini, Nika Niknejad
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2013-06-01
Series:Iranian Journal of Otorhinolaryngology
Subjects:
Online Access:http://ijorl.mums.ac.ir/?_action=showPDF&article=663&_ob=9eee4c5d4cf5b0265eb30dc9f2d4f102&fileName=full_text.pdf
_version_ 1818523102075682816
author Bijan Khademi
Behzad Khademi
Abbas Ghaderi
Seyd Fakhroddin Hosseini
Nika Niknejad
author_facet Bijan Khademi
Behzad Khademi
Abbas Ghaderi
Seyd Fakhroddin Hosseini
Nika Niknejad
author_sort Bijan Khademi
collection DOAJ
description Introduction: The presence of HER-2 has been shown to be a prognostic factor in many kinds of cancers, but its role in head and neck squamous cell carcinoma (HNSCC) is not still defined. The purpose of the current study is to investigate the role of HER-2 in HNSCC and its correlation with various clinicopathologic parameters.   Materials and Methods: Peripheral blood samples were obtained from 17 healthy volunteers and 69 patients with HNSCC before curative surgery. The HER-2 level was determined in each sample sandwich by ELISA. Statistical analysis was performed using an independent t-test, one-way ANOVA, and the Duncan procedure.   Results: Mean HER-2 serum levels were higher in patients with HNSCC compared with healthy controls, although the difference was not statistically significant (3.85ng/ml vs. 3.75ng/ml; P>0.05). The mean serum level of HER-2 in patients with was higher in patients with lymph node involvement, metastasis, invasion, tumor size ≥ 2 cm, and stage >1, although the differences were not statistically significant (P>0.05).   Conclusion: In this study the mean HER-2 serum level in patients with HNSCC was found to be greater in comparison with the healthy control group, although the difference was statistically insignificant. From the analysis of the results of the current study we have come to the conclusion that by increasing sample size the rising of the serum HER-2 level in patients with HNSCC can be meaningful. Apart from this, the role of HER-2 as a tumor marker in patients with HNSCC is still controversial and needs further studies to clarify the significance of this biomarker for early detection or screening for HNSCC.
first_indexed 2024-12-11T05:41:04Z
format Article
id doaj.art-e6736313ba3b43689b544d3ea30692e1
institution Directory Open Access Journal
issn 2251-7251
2251-726X
language English
last_indexed 2024-12-11T05:41:04Z
publishDate 2013-06-01
publisher Mashhad University of Medical Sciences
record_format Article
series Iranian Journal of Otorhinolaryngology
spelling doaj.art-e6736313ba3b43689b544d3ea30692e12022-12-22T01:19:07ZengMashhad University of Medical SciencesIranian Journal of Otorhinolaryngology2251-72512251-726X2013-06-012572161167Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell CarcinomaBijan KhademiBehzad KhademiAbbas GhaderiSeyd Fakhroddin HosseiniNika NiknejadIntroduction: The presence of HER-2 has been shown to be a prognostic factor in many kinds of cancers, but its role in head and neck squamous cell carcinoma (HNSCC) is not still defined. The purpose of the current study is to investigate the role of HER-2 in HNSCC and its correlation with various clinicopathologic parameters.   Materials and Methods: Peripheral blood samples were obtained from 17 healthy volunteers and 69 patients with HNSCC before curative surgery. The HER-2 level was determined in each sample sandwich by ELISA. Statistical analysis was performed using an independent t-test, one-way ANOVA, and the Duncan procedure.   Results: Mean HER-2 serum levels were higher in patients with HNSCC compared with healthy controls, although the difference was not statistically significant (3.85ng/ml vs. 3.75ng/ml; P>0.05). The mean serum level of HER-2 in patients with was higher in patients with lymph node involvement, metastasis, invasion, tumor size ≥ 2 cm, and stage >1, although the differences were not statistically significant (P>0.05).   Conclusion: In this study the mean HER-2 serum level in patients with HNSCC was found to be greater in comparison with the healthy control group, although the difference was statistically insignificant. From the analysis of the results of the current study we have come to the conclusion that by increasing sample size the rising of the serum HER-2 level in patients with HNSCC can be meaningful. Apart from this, the role of HER-2 as a tumor marker in patients with HNSCC is still controversial and needs further studies to clarify the significance of this biomarker for early detection or screening for HNSCC.http://ijorl.mums.ac.ir/?_action=showPDF&article=663&_ob=9eee4c5d4cf5b0265eb30dc9f2d4f102&fileName=full_text.pdfHNSCCHER-2
spellingShingle Bijan Khademi
Behzad Khademi
Abbas Ghaderi
Seyd Fakhroddin Hosseini
Nika Niknejad
Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma
Iranian Journal of Otorhinolaryngology
HNSCC
HER-2
title Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma
title_full Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma
title_fullStr Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma
title_full_unstemmed Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma
title_short Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma
title_sort early detection of serum levels of her 2 in patients with head and neck squamous cell carcinoma
topic HNSCC
HER-2
url http://ijorl.mums.ac.ir/?_action=showPDF&article=663&_ob=9eee4c5d4cf5b0265eb30dc9f2d4f102&fileName=full_text.pdf
work_keys_str_mv AT bijankhademi earlydetectionofserumlevelsofher2inpatientswithheadandnecksquamouscellcarcinoma
AT behzadkhademi earlydetectionofserumlevelsofher2inpatientswithheadandnecksquamouscellcarcinoma
AT abbasghaderi earlydetectionofserumlevelsofher2inpatientswithheadandnecksquamouscellcarcinoma
AT seydfakhroddinhosseini earlydetectionofserumlevelsofher2inpatientswithheadandnecksquamouscellcarcinoma
AT nikaniknejad earlydetectionofserumlevelsofher2inpatientswithheadandnecksquamouscellcarcinoma